BPTH - Bio-Path Holdings, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
31.69M
Enterprise Value 3
14.22M
Trailing P/E
N/A
Forward P/E 1
-3.29
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
1.74
Enterprise Value/Revenue 3
N/A
Enterprise Value/EBITDA 6
-1.76

Trading Information

Stock Price History

Beta (3Y Monthly) 3.68
52-Week Change 3-4.91%
S&P500 52-Week Change 38.78%
52 Week High 373.52
52 Week Low 31.61
50-Day Moving Average 310.56
200-Day Moving Average 313.64

Share Statistics

Avg Vol (3 month) 367.02k
Avg Vol (10 day) 381.33k
Shares Outstanding 52.88M
Float 2.45M
% Held by Insiders 15.62%
% Held by Institutions 128.47%
Shares Short (Sep 30, 2019) 4181.06k
Short Ratio (Sep 30, 2019) 43.35
Short % of Float (Sep 30, 2019) 47.32%
Short % of Shares Outstanding (Sep 30, 2019) 46.28%
Shares Short (prior month Aug 30, 2019) 4232.97k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 220/1
Last Split Date 3Jan 18, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-41.86%
Return on Equity (ttm)-79.10%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -8.08M
Net Income Avi to Common (ttm)-8.96M
Diluted EPS (ttm)-6.19
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)17.11M
Total Cash Per Share (mrq)5.93
Total Debt (mrq)407k
Total Debt/Equity (mrq)2.27
Current Ratio (mrq)18.01
Book Value Per Share (mrq)6.33

Cash Flow Statement

Operating Cash Flow (ttm)-6.98M
Levered Free Cash Flow (ttm)-3.82M